Teton Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,400
Closed -$312K 281
2022
Q2
$312K Hold
1,400
0.07% 236
2022
Q1
$770K Hold
1,400
0.13% 187
2021
Q4
$925K Hold
1,400
0.13% 187
2021
Q3
$1.18M Hold
1,400
0.17% 154
2021
Q2
$1.78M Hold
1,400
0.24% 112
2021
Q1
$1.54M Sell
1,400
-2,100
-60% -$2.77M 0.22% 119
2020
Q4
$5M Sell
3,500
-1,300
-27% -$1.39M 0.7% 28
2020
Q3
$3.39M Sell
4,800
-600
-11% -$436K 0.58% 35
2020
Q2
$3.78M Sell
5,400
-2,400
-31% -$1.39M 0.61% 35
2020
Q1
$2.73M Sell
7,800
-2,450
-24% -$1.74M 0.44% 55
2019
Q4
$6.44M Sell
10,250
-1,150
-10% -$562K 0.65% 38
2019
Q3
$3.82M Hold
11,400
0.39% 63
2019
Q2
$2.96M Sell
11,400
-100
-0.9% -$20K 0.29% 88
2019
Q1
$1.9M Buy
11,500
+1,500
+15% +$244K 0.19% 147
2018
Q4
$1.08M Buy
10,000
+7,100
+245% +$1.2M 0.12% 203
2018
Q3
$726K Buy
+2,900
New +$624K 0.06% 284

Other funds holding CDLX

Teton Advisors's CDLX Position: Q3 2022 in Review

Teton Advisors sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 1,400 shares — an estimated $312K sold.

Teton Advisors first reported a position in CDLX in Q3 2018 and held it in 16 quarters. The position peaked at $6.44M in Q4 2019. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Teton Advisors reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Teton Advisors sold 1,400 Cardlytics shares in Q3 2022, an estimated $312K.
  • Teton Advisors first reported a position in Cardlytics in Q3 2018 and held it in 16 quarters.
  • Teton Advisors's Cardlytics position peaked at $6.44M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Teton Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.